---
schema_version: "secwatch.filing_event.v1"
accession: "0001023024-25-000006"
form_type: "8-K"
ticker: "ANIP"
cik: "0001023024"
company_name: "ANI PHARMACEUTICALS INC"
filed_at: "2025-02-05T23:59:59+00:00"
generated_at: "2026-05-27T02:18:18.933844+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# ANI Pharmaceuticals presents at Guggenheim Biotech Conference; no material news disclosed in filing

## Summary
- Investor presentation furnished as Exhibit 99.1 for Guggenheim Biotech Conference on Feb 5, 2025, but content not provided in this excerpt.
- No specific financial results, guidance, or material events are disclosed in the Form 8-K filing.
- The filing only notes the presentation; substantive information is missing from the exhibit appended to this analysis.

## SEC filing metadata
- accession: 0001023024-25-000006
- form_type: 8-K
- ticker: ANIP
- cik: 0001023024
- company_name: ANI PHARMACEUTICALS INC
- filed_at: 2025-02-05T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1023024/000102302425000006/0001023024-25-000006-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1023024/000102302425000006/ani-20250205.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001023024-25-000006
- JSON: https://secwatch.observer/filing/0001023024-25-000006.json
- Plain text: https://secwatch.observer/filing/0001023024-25-000006.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.